Villacrusis, Vilma D.

HRN: 24-98-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2024
MUPIROCIN 2%, 15G (TUBE)
05/12/2024
05/18/2024
TOPICAL
Ample Amount
BID
Folloculitis
Waiting Final Action 
05/15/2024
CO-AMOXICLAV 625MG (TAB)
05/15/2024
05/22/2024
PO
625mg
TID
Multiple Folliculitis
Waiting Final Action 
05/15/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/15/2024
05/22/2024
IV
600mg
Q8
Multiple Folliculitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: